Cristina Guarducci

7PUBLICATIONS
86CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 08, 2024
Pure estrogen receptor antagonists potentiate capecitabine activity in ESR1-mutant breast cancer.

Albert Grinshpun, Douglas Russo, Wen Ma

|Mar 01, 2024
Mutational Analysis of Circulating Tumor DNA in Patients With Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer Receiving Palbociclib: Results From the TREnd Trial.

Ilenia Migliaccio, Dario Romagnoli, Francesca Galardi

|Feb 21, 2024
Selective CDK7 Inhibition Suppresses Cell Cycle Progression and MYC Signaling While Enhancing Apoptosis in Therapy-resistant Estrogen Receptor-positive Breast Cancer.

Cristina Guarducci, Agostina Nardone, Douglas Russo

|Nov 03, 2023
Mathematical Modeling Identifies Optimum Palbociclib-fulvestrant Dose Administration Schedules for the Treatment of Patients with Estrogen Receptor-positive Breast Cancer.

Yu-Chen Cheng, Shayna Stein, Agostina Nardone

|Jul 14, 2023
Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor-Positive Breast Cancer.

Francisco Hermida-Prado, Yingtian Xie, Shira Sherman

|Aug 11, 2022
A Distinct Chromatin State Drives Therapeutic Resistance in Invasive Lobular Breast Cancer.

Agostina Nardone, Xintao Qiu, Sandor Spisak

Pageof 2

Frequent Collaborators

5 joint publications

Agostina Nardone

5 joint publications

Rinath Jeselsohn

3 joint publications

Douglas Russo

3 joint publications

Luca Malorni